CTS Spotlight at 2018 AABB Annual Meeting
Sunday, October 14, 2018 at 1:30 PM: Scientific Oral Abstract Plenary Session (BBC57) Multicenter Clinical Evaluation of a Babesia Transcription-Mediated Amplification Assay on a Fully Automated System Phillip C. Williamson, Ph.D.
Monday, October 15, 2018 at 2:30PM: (BBC2-MN3-24) Recently Acquired Hepatitis C Infections in US Blood Donors: Genotype and Geographic Distribution of NAT Yield Blood Donations across the Continental US Valerie Winkelman and Phillip C. Williamson, Ph.D.
Tuesday, October 16, 2018 at 11:45AM a: (PHP2 - TU3-23) Characteristics of HIV Infections, Including Genotypes and Drug Resistance Mutations, in Blood Donors in the US Phillip C. Williamson, Ph.D.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...